Back to search
FDAFDA · Food and drugs·Recall number Z-1482-2025

Hemopore 2PK nasal/sinus temporary wound dressing, Catalog Number 5400-222-208S

Published April 9, 2025 · Recall initiated: February 25, 2025

Summary

FDA records medical device Class II recall Z-1482-2025, published April 9, 2025 and initiated February 25, 2025. Recalling firm: Stryker Corporation; Status: Ongoing; Reported quantity: 182,344 total units; Lot: 5400-222-208S UDI-DI: 07613327500486, Lot Numbers: 2024020221 2024051720 2024082321. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Stryker Corporation
Distributor
US Nationwide distribution.
Lot
5400-222-208S UDI-DI: 07613327500486, Lot Numbers: 2024020221 2024051720 2024082321
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Hemopore 2PK nasal/sinus temporary wound dressing, Catalog Number 5400-222-208S recalled?

Yes. FDA published recall Z-1482-2025 on April 9, 2025. Reported hazard: There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.

What should I do if I have this product?

Voluntary: Firm initiated · Letter